NIH-funded research R01 grant

How high PHD2 levels may make aging muscles repair and respond to exercise less well

Official title: PHD2 mediated loss of hypoxia signaling limits skeletal muscle regeneration and exercise response in aging

Funded at Brigham and Women's Hospital · NIH-11299055 · Data updated 2026-11-12

Researchers are testing whether lowering a protein called PHD2 can help older muscles heal better and get more benefit from aerobic exercise.

More Aging research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBrigham and Women's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startApril 1, 2023
Project endMarch 31, 2028
Funding year2026
Award (this year)$392,638
NIH project number5R01AG078307-04
Project IDNIH-11299055 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be older adults with age-related muscle weakness, reduced exercise tolerance, or poor muscle recovery after injury or activity.

Less likely to help

People whose muscle problems come from acute traumatic injury, specific genetic muscle diseases, or conditions unrelated to aging may be less likely to benefit from this work.

What this research studies

If you are an older adult worried about losing muscle or not improving with exercise, this work looks at one reason why that happens. The team uses aging mice and genetically modified animals to study how PHD2, a protein that rises with age, changes oxygen-sensing signals in muscle and harms repair and exercise adaptation. They will test whether blocking PHD2 restores the muscle’s ability to regenerate and to get fitter from aerobic training, and they compare mouse findings with gene activity seen in human muscle samples. The goal is to point toward treatments that keep muscles stronger and more responsive to activity as people age.

Why it matters

Potential benefit: If successful, the research could lead to new therapies that improve muscle repair and enhance exercise benefits for older adults.

How similar studies have gone: Preclinical studies targeting hypoxia pathways and PHD enzymes have shown promise in animal models, but translating these approaches to human treatments remains limited and early.

Where this research is happening

  • Brigham and Women's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Sinha, Indranil — Brigham and Women's Hospital
  • Study coordinator: Sinha, Indranil

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.